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Summary
SPA-1 (signal-induced proliferation-associated gene-1) is a principal Rap1 GTPase-activating protein in hematopoietic
progenitors. SPA-1-deficient mice developed a spectrum of myeloid disorders that resembled human chronic myelogenous
leukemia (CML) in chronic phase, CML in blast crisis, and myelodysplastic syndrome as well as anemia. Preleukemic
SPA-1-deficient mice revealed selective expansion of marrow pluripotential hematopoietic progenitors, which showed
abnormal Rap1GTP accumulation. Overexpression of an active form of Rap1 promoted the proliferation of normal hemato-
poietic progenitors, while SPA-1 overexpression markedly suppressed it. Furthermore, restoring SPA-1 gene in a SPA-1-
deficient leukemic blast cell line resulted in the dissolution of Rap1GTP accumulation and concomitant loss of the leukemo-
genicity in vivo. These results unveiled a role of Rap1 in myeloproliferative stem cell disorders and a tumor suppressor
function of SPA-1.
Introduction et al., 2000; Reedquist et al., 2000; Tsukamoto et al., 1999) and
regulated various integrin-dependent cellular functions (Caron
Ras mutations are responsible for many types of human malig- et al., 2000; Katagiri et al., 2002; Sebzda et al., 2002; Shimonaka
nancy (Bos, 1988), and Rap1, a close member of Ras-family et al., 2003).
GTPases, has been discovered originally as a protein counter- Activation of Rap1 by extracellular signals is mediated by
acting the functions of oncogenic K-Ras in a fibroblast cell line various kinds of guanine nucleotide exchange factors (GEF),
(Kitayama et al., 1989). Rap1 shows the highest homology to including C3G regulated by receptor-associated protein tyro-
Ras among the family and shares several downstream effecter sine kinases (Gotoh et al., 1995), Epac directly regulated by
molecules with Ras, including Raf family kinases (Bos et al., cAMP (de Rooij et al., 1998), and CalDAG-GEF activated by
2001), and it was reported that Rap1GTP either attenuated Ras- Ca2 and DAG (Kawasaki et al., 1998), while Rap1GTP is inacti-
vated to Rap1GDP by specific GTPase-activating proteinsmediated ERK activation via competitive interference with
c-Raf-1 activation (Cook et al., 1993; Hu et al., 1997) or induced (GAP). At present, two groups of Rap1GAPs sharing a catalytic
GAP-related domain (GRD) are identified, rapGAP I, II (MochizukiERK activation directly via B-Raf activation (Vossler et al., 1997;
York et al., 1998) depending on the types of model cell lines. et al., 1999; Rubinfeld et al., 1991) and SPA-1 (signal-induced
proliferation-associated gene-1) family proteins includingOn the other hand, evidence has been accumulated that Rap1
mediated the activation of integrins (Arai et al., 2001; Katagiri SPA-1(Hattori et al., 1995; Kurachi et al., 1997), E6TP1 (Gao et
S I G N I F I C A N C E
Rap1 GTPase was isolated originally as a potential antagonist of oncogenic K-Ras over a decade ago. While several biological
functions of Rap1 were revealed in cell line models since then including modulation of Ras-ERK signaling and activation of integrins,
its possible involvement in malignancy remained unknown. By using the mice targeted for SPA-1 gene encoding a Rap1-specific
GTPase-activating protein, we demonstrate that deregulated activation of Rap1 in the hematopoietic stem cells results in a spectrum
of myeloid disorders that resemble human CML in chronic phase, CML in blast crisis, and MDS. Here we indicate that abnormal Rap1
activation causes malignancy in vivo and uncovers the role of SPA-1 as a tumor suppressor in hematopoietic stem cells.
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al., 1999), and SPAR (Pak et al., 2001), which appear to have Development of a spectrum of myeloid disorders
in SPA-1-deficient micedifferent tissue distribution. In addition, tuberin, a product of
tuberous sclerosis-2 gene in human, shows a partial homology SPA-1/ mice were born and developed normally. After around
a year, however, all the SPA-1/ mice started to reveal abnor-to GRD and is reported to exhibit Rap1GAP activity (Wienecke
et al., 1995). The Rap1GAPs plays a major role in the spatio- mal peripheral blood (PB) leukocyte numbers and anemia (Fig-
ure 2A). The mice were sacrificed for autopsy when they devel-temporal control of intracellular Rap1 activation (Ohba et al.,
2003). We reported that Rap1GAPs were bound to AF-6 (afadin), oped life-threatening anemia of less than 6  106 RBC/mm3 or
leukocytosis over 40  103 cells/ mm3, or when they apparentlya fusion partner of ALL1 in human myeloid leukemia (Prasad et
al., 1993), via a conserved GRD, through which the accessibility became sick. In 14 out of the total 60 SPA-1/ mice of the
present cohort (group I), PB leukocytes were increased, whichto Rap1GTP could be regulated (Su et al., 2003).
Several recent reports have suggested the involvement of were predominated by mature granulocytes with few blast cells
(Figure 2B). These mice exhibited marked splenomegaly withdysregulated Rap1signaling in malignancy. It was reported that
E6TP1 was targeted for degradation by oncogenic human papil- extensive extramedullary hematopoiesis of all the lineages in-
cluding abundant erythroblasts (Figures 2A and 2B). BMs werelomavirus E6 protein via E6AP ubiquitin ligase in epithelial cells
(Gao et al., 2002), which highly paralleled the cellular transforma- pale, hypercellular, and predominated by maturated myeloid
cells with markedly reduced erythroid component (Figure 3A).tion by E6 oncoprotein (Gao et al., 2001). It was indicated also
that CalDAG-GEFI was activated recurrently by proviral insertion These features resembled human CML in chronic phase (cp).
A minor group (group II, eight mice) showed pancytopenia within leukemia-prone BXH-2 recombinant strain of mice (Dupuy et
al., 2001). Most recently, it was reported that a subset of human dysplastic granulocytes, large mono- or binuclear megakaryo-
cytic cells, and some blastic cells in the PB (Figures 2A andcancer cell lines showed missense mutations of DOCK4 gene
that encoded a Rap1-activating protein regulating intercellular 2B). The spleens were enlarged albeit less markedly, and the
BMs often revealed mosaic hyperplastic and hypoplastic re-junctions, and the protein with a recurrent mutation was defec-
tive in Rap1 activation (Yajnik et al., 2003). In the present study, gions, reminiscent of human MDS (Figure 3A). The rest (group
III, 35 mice) exhibited peripheral leukocytosis containing varyingwe report that SPA-1 is a principal GAP for Rap1 in hematopoi-
etic progenitors, and null mutant mice of SPA-1 gene (SPA-1/) proportions (14% to 85%) of blast cells (Figures 2A and 2B).
The blast cells were of diverse lineages including myeloid, ery-develop a spectrum of myeloid disorders that resemble human
chronic myelogenous leukemia (CML) in chronic phase, CML throid, B and mixed lineages (Mac-1B220) except for T lin-
eage, and extensively infiltrated in BM and other vital organsin blast crisis, and myelodysplastic syndrome (MDS), unveiling
a role of SPA-1 as a tumor suppressor of myeloid malignancy. (Figures 2B, 3A, and 3B). Southern blot analysis for immuno-
globulin heavy chain gene indicated that at least B220 blast
cells were mono- or oligoclonal (Figure 3C). Overall, 95% ofResults
SPA-1/ mice developed these myeloid disorders by 16
months. Transfer of the spleen cells from a group I mouse intoSPA-1 is a principal Rap1GAP in the immature bone
marrow cells SCID mice induced essentially identical cp-CML-like disease,
and that of either PB or BMC from a group III mouse causedIn the normal bone marrow cells (BMC), both types of Rap1-
GAPs, SPA-1 and rapGAP, were expressed. Cell fractionation marked increase in the blast cells with heavy infiltration into
vital organs within 2 months (Table 1). It was noted that oneanalysis, however, revealed that lineage marker-negative (lin)
immature BMC almost exclusively expressed SPA-1, while lin recipient of the group III PB developed cp-CML-like disease.
While SPA-1/ littermates (50 mice) showed no evidence of(Gr-1 Mac-1 Ter119) BMC contained rapGAP with marginal
SPA-1 (Figure 1A). Rap1 expression was comparable between myeloid disorders until 20 months, 15% of SPA-1/ littermates
(16 out of 102 mice) developed abnormal hematological findingsthe two populations. We also examined an IL-3-dependent pro-
myeloblastic cell line (32D), which could be induced to differenti- (the mean WBC, 22.3  5.8  103 cells/mm3 and RBC, 6.35 
0.6  106 cells/mm3 versus 8.7  0.04  103 cells/mm3 andate into mature granulocytes in the presence of G-CSF. As
also shown in Figure 1A, 32D cells growing in IL-3-containing 9.31 0.04 106 cells/mm3 in SPA-1/ mice) with splenomeg-
aly, among which four mice showed CML in chronic phase andmedium expressed SPA-1 with marginal rapGAP. After the shift
to G-CSF-containing medium, the cells gradually lost SPA-1 the rest CML in blast crisis.
expression (day 3), and the maturated and growth-arrested
granulocytes exhibited undetectable SPA-1 with significant rap- Increase in pluripotent hematopoietic progenitors
in SPA-1-deficient miceGAP instead (day 5). These results indicated that expression of
Rap1GAP species in immature myeloid cells was shifted from We first examined the numbers of committed hematopoietic
progenitors (CFU-C) in SPA-1/ mice with cp-CML. As shownSPA-1 to rapGAP according to their maturation and that SPA-1
was a principal Rap1GAP in the immature hematopoietic pro- in Figure 4A, frequencies of CFU-C of all the lineages were
increased in particular GM-CFU-C in the BMs and E- and Mix-genitors. To explore the roles of SPA-1 in vivo, we generated
SPA-1 gene-targeted mice by homologous recombination, re- CFU-C in the spleens with average colony sizes being largely
unchanged. Since total nucleated cell numbers in the spleensplacing exons 5 to 8 encoding GRD with a neo-containing tar-
geting vector (Figure 1B). Mice homozygous for the mutant allele and BMs were increased up to 50 times and 1.5 to 2 times,
respectively, the overall CFU-C were estimated to reach nearly(SPA-1/) expressed no detectable 130 kDa SPA-1 protein,
while heterozygous mice (SPA-1/) exhibited roughly half a 100 times of the control mice. Furthermore, significant num-
bers of E- and Mix-CFU-C were detected in the circulation oflevel of SPA-1 showing a gene-dosage effect (Figure 1B). Ex-
pression of its substrate Rap1 was unaffected by the SPA-1 SPA-1/ mice, suggesting either premature dislodgment or
“spill-over” of the expanded progenitors. We then examinedmutation.
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Figure 1. Selective expression of SPA-1 in hematopoietic progenitors and generation of SPA-1 gene-targeted mice
A: Cell lysates of the total as well as lin and lin (Gr-1Mac-1Ter119) fractions of BMC from normal B6 mice and 32D promyeloblastic cells before and
after the culture with G-CSF (10 ng/ml) were immunoblotted with anti-SPA-1, anti-rapGAP, anti-Rap1, and anti-ERK2 as a loading control. Over 75% of 32D
cells were mature granulocytes on day 5 after the culture with G-CSF.
B: Exons 5 to 8 encoding GRD of SPA-1 gene were replaced by a pgk-neo using an indicated targeting vector. BamHI- and SacI-digested genomic DNAs
were Southern blotted with TP4 and neo probes, respectively, and spleen cell lysates were immunoblotted with anti-SPA-1 or anti-Rap1.
the progenitors in the BMs of preleukemic SPA-1/ mice. As mostly underneath the stroma cells as compared with that of
vector control, while overexpression of SPA-1 caused markedshown in Figure 4B, both lin c-kithigh progenitor cells and lin
Sca-1 c-kithigh population representing hematopoietic stem suppression. We also transferred the transfected cells along
with normal BMC into the lethally irradiated BALB/c mice. Atcells were significantly increased in the BMC of preleukemic
SPA-1/ mice as compared with the control mice. The mean 3 weeks after the transfer, RapE63-transfected progenitors
showed enhanced expansion in the BM as compared with theproportion of lin Sca-1 c-kithigh cells (HSC) in SPA-1/ mice
was increased significantly already at 3 months, and was accel- mock-transfected progenitors (Figure 4B), mean GFP cell pro-
portions in the original donor population and the recipient BMCerated further at 8 months, while that in the control littermates
remained unchanged (Figure 4B). To examine whether the in- being 19% and 32%, respectively, for the former, and 20% and
19% for the latter. FACS analysis revealed that the RapE63-crease reflected hypersensitivity of the progenitors to hemato-
poietic factors, lin c-kithigh cells were sorted from the BMC and transfected progenitors differentiated comparably to the con-
trols in the BMs and even better in the spleens (Figure 4C). Thecultured in the presence of varying concentrations of GM-CSF.
As shown in Figure 4C, sensitivity of the isolated progenitors results suggested that endogenous Rap1 signaling promoted
the expansion of hematopoietic progenitors without compro-from SPA-1/ mice to GM-CSF per se was indistinguishable
from that of the control mice; this effect was associated also mising their differentiation potential.
with the comparable differentiation into mature lin myeloid
cells. Crucial role of excess Rap1 signaling in the
leukemogenicity of blast cells in vivo
Spleen cells of the SPA-1/ mice with cp-CML that consistedRole of Rap1 signaling in the proliferation
of hematopoietic progenitors mostly of mature granulocytes revealed no detectable Rap1GTP
like normal spleen cells (Figure 6A), probably reflecting the matu-The lin BMC population pooled from preleukemic SPA-1/
mice revealed marked accumulation of Rap1GTP as expected, ration-related shift of Rap1GAP from SPA-1 to rapGAP (see
Figure 1A). In contrast, spleen cells from the mice with CML inwhile it was below the detection level in the same fraction of
control littermates (Figure 5A). The lin BMC from SPA-1/ blast crisis showed significant Rap1GTP accumulation in pro-
portion to the blast cell contents (Figure 6A); this was compatiblemice also showed significantly enhanced ERK activation as
compared with the control, while the amount of RasGTP was with their arrested maturation. They also exhibited marked ERK
activation, which was associated with strong Ras activationnot increased (Figure 5A). In order to directly investigate the
role of Rap1 signaling in the normal progenitors, sorted lin unlike the preleukemic BM progenitors (Figure 6A). In an attempt
to investigate the roles of Rap1 signaling in the leukemic blastcells from the pooled BMC of normal BALB/c mice pretreated
with 5-FU were infected in vitro with a recombinant MSCV- cells, we established a cell line (1629B) from a SPA-1/ mouse
with CML in blast crisis. 1629B cells were immature blastic cellsIRES/EGFP (MIE) retrovirus containing RapE63 or SPA-1 cDNA
and cultured on PA6 stroma cells. As shown in Figure 5B, trans- (Figure 6B), whose phenotypes were CD45, Sca-1high, c-kit/low,
CD34, Mac-1low, Gr-1, Ter /low, B220, and CD3. The cellsfection of RapE63 resulted in the enhanced cellular expansion
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Figure 2. Hematological abnormalities in SPA-1/ mice
A: Hemograms of 10- to 16-month-old SPA-1/ and / littermates. Abnormalities in the blood leukocytes of SPA-1/ mice were classified into three groups.
I, leukocytosis with few blast cells (14 out of 60 mice); II, pancytopenia (8 out of 60 mice); and III, leukocytosis with varying proportions (14%–85%) of blast
cells (35 out of 60 mice).
B: Marked splenomegaly (a bar indicating 10 mm) and abnormal leukocytes in the peripheral blood of SPA-1/ mice. Heparinized bloods from SPA-1/
mice were treated with hypotonic buffer to lyse RBC, cyto-spun, and stained with May-Grunwald Giemza solution (original magnification; 1,000). Aliquots
of them were analyzed for the indicated markers using FACScan, the mean percentages of ten control mice being indicated in parenthesis. Representative
pictures of groups I to III are shown. Note the dysplastic granulocytes and large megakaryocytic cells in #1581 and abundant erythroblasts in # 1437
SPA-1/ mice.
could be propagated continuously in the presence of functional (Figure 6D), confirming that the accumulation of Rap1GTP was
a direct consequence of endogenous SPA-1 deficiency. In con-stroma cell lines (PA6, Tst-4). They grew underneath the stroma
cells like cobblestones (Figure 6B), while they died off within trast, both Ras and ERK activation were not affected in 1629B/
SPA-1 cells (Figure 6D), suggesting that the ERK activation was2 days in the absence of stroma cells (Figure 6C). Neither adher-
ent cell lines incapable of supporting normal hematopoiesis mediated by constitutive Ras activation that was independent
of Rap1 signaling in the blast cells. 1629B/SPA-1 cells grew(NIH3T3, endothelial F2) nor any soluble hematopoietic factors
could support their survival at all (Figure 6C). Also, culture of comparably to or even better than 1629B/GFP cells, while they
continued to be dependent on the stroma cells for survival.them with stoma cells in combination with various hematopoi-
etic factors induced little sign of differentiation (data not shown), The growth of both cells in the presence of stroma cells was
suppressed by a MEK inhibitor, indicating that the constitutivesuggesting that their differentiation potential was arrested irre-
versibly. 1629B cells showed large amounts of Rap1GTP as Ras-ERK signaling, but not Rap1 signaling, was responsible for
the continuous growth on the stroma cells in vitro (Figure 6D).well as strong Ras and ERK activation like the blast cells in vivo
(Figure 5D) and caused lethal leukemia in SCID mice, strongly Nonetheless, when transferred into unirradiated SCID mice, no
signs of leukemia developed in any recipients of 1629B/SPA-1suggesting that they represented the blast cells in the crisis.
In an attempt to abrogate excess Rap1 activation, we in- cells, while seven out of eight recipients transferred with the
same numbers of 1629B/GFP cells developed blastic leukemiafected the 1629B cells with MIE-SPA-1 or an empty MIE retrovi-
rus as a control, sorted twice for GFP cells up to over 95% associated with anemia in 7 weeks (Figure 6E). The vast majority
of leukocytes in the latter were blast cells of donor origin (H-2b),purity, and expanded without cloning to avoid clonal variance.
As expected, 1629B/SPA-1 cells showed undetectable Rap1GTP, and all the 7 recipients died by 11 weeks with massive hepato-
splenomegaly and blast cell infiltration into the vital organs (Fig-while control cells (1629B/GFP) contained abundant Rap1GTP
58 CANCER CELL : JULY 2003
A R T I C L E
Figure 3. Histology of the BMs and other organs of leukemic SPA-1/ mice and clonality of blast cells
A: Representative H-E stained pictures of the BMs from diseased SPA-1/ mice (original magnifications,40 and400). Note the increase in well-maturated
myeloid cells (group I), hypoplastic region (group II), and monotonous blastic cells (group III) all associated with marked reduction of erythroid components.
B: Infiltration of leukemic cells in the vital organs of group III SPA-1/ mice (H-E stain, original magnification, 200).
C: Southern blotting analysis of EcoRI and BamHI-digested DNAs from SPA-1/ spleens containing B220 blast cells as well as control spleen and liver using
an immunoglobulin JH cDNA probe. Solid arrowhead, germline band; open arrowheads, rearranged bands.
ure 6E). Although three out of the eight recipients of 1629B/ that the leukemia was due to the selective outgrowth of minor
1629B cells without a transfected SPA-1 cDNA. The resultsSPA-1 cells ultimately developed similar leukemia with several
weeks delay, the enlarged spleens containing over 90% donor clearly indicated that the persistent Rap1 signaling played a
crucial role for the leukemogenicity of blast cells in vivo.blast cells expressed no SPA-1 cDNA (Figure 6F), indicating
Table 1. Transfer of the myeloproliferative diseases of SPA-1/ mice into SCID mice
PB BMC
Recipient WBC Gr-1 Mac-1 Ter SPL weight Gr-1 Mac-1 Ter
Donor Cells No. no. (/l) (%) (%) (%) (mg) (%) (%) (%)
Control BMC 4 1,480 85.8 5.5 115 46.9 1.3 39.1
(40) (0.7) (3.5) 1 (52) (9.9) (0.5) (8.7)
#861 SPL 4 17,400 91.2 1 1 382 80.4 1.1 11.7
(2,020) (3.0) (44) (1.0) (3.9) (3.0)
4 Dead before 6 weeks
[36,100 65.1 4.1 1 5,500 65.1 1.1 2.1]
#1438 BMC 2 42,050 9.5 70.2* 8.8 408 39.4 37.4* 8.9
SPL 2 3,500 33.3 35.4* 10.9 240 64.4 3.7 18.1
PB 3 42,600 5.4 82.6* 9.9 432 37.9 38.4* 10.7
(27,900) (0.8) (4.2) (9.2) (88) (14.3) (9.5) (5.3)
1 10,000 92.1 1 8.3 142 85.3 1 9.1
[370,000 4.3 88.7* 1 3,324 53.8 22.5* 11.7]
Cells from the SPA-1/ mice with cp-CML-like (#861) or AML (#1438), or age-matched control mice were injected i.v. into 2.75 G -ray irradiated SCID
mice at 5  106 cells/mouse. Recipient mice were sacrificed at 6 to 9 weeks for histohematological examination. Four out of eight recipients of #861 cells
died before 6 weeks escaping the analysis. The vast majority of Mac-1 cells in the #1438 recipients were Mac-1low blasts (*), which heavily infiltrated into
vital organs. (): standard errors. []: Data of the original donor mice.
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principal Rap1GAP in the immature hematopoietic progenitors.
The vast majority of SPA-1/mice developed myeloid leukemia
that resembled human CML in cp and in blast crisis from around
a year old onward. While 15% of SPA-1/ mice also developed
CML, it remained to be investigated whether the leukemia was
associated with mutations or deletion of a wild-type SPA-1
allele. The mice with cp-CML showed marked increase in the
committed progenitors of all the lineages, which was transfer-
able into SCID mice and thus progenitor cell autonomous. Evi-
dence for the increase in pluripotential hematopoietic progeni-
tors was detected in the BM of preleukemic SPA-1/ mice at
as early as 3 months. This increase was accelerated further as
mice aged. BM progenitors in the preleukemic SPA-1/, but
not control, mice showed marked accumulation of Rap1GTP
as expected. It was indicated that retrovirus-mediated expres-
sion of an active mutant of Rap1 (RapE63) significantly en-
hanced the proliferation of normal hematopoietic progenitors
on stroma cells in vitro as well as in the BM of lethally irradiated
mice in vivo without compromizing their differentiation. Thus, it
was suggested that the persistent Rap1 signaling was responsi-
ble for the accelerated hematopoiesis in SPA-1/ mice. Al-
though there was a significant increase in HSC fraction in the
BM of preleukemic SPA-1/ mice, it remained to be verified
carefully whether Rap1 signaling controlled the self-renewal ca-
pacity of HSC per se.
The preleukemic progenitors in the BM of SPA-1/ mice
showed enhanced activation of ERK, while Ras activation was
comparable to or less than that in the control progenitors. The
results implied that Rap1 signaling directly activated ERK, via
B-Raf for instance (Mikula et al., 2001), or synergistically potenti-
ated Ras-mediated ERK activation as recently reported in neu-
ronal cells (Bouschet et al., 2003). It was reported that mice
deficient for NF-1, a RasGAP, showed enhanced Ras activation
and hypersensitivity to GM-CSF leading to the development of
Figure 4. Increase in the hematopoietic progenitors in SPA-1/ mice CML (Birnbaum et al., 2000; Bollag et al., 1996; Largaespada
A: CFU-Cs in the BMC, spleen, and PB of a SPA-1/ mouse with cp-CML et al., 1996). Mice lacking JunB expression in myeloid progeni-
(closed bars) and age-matched control littermate (open bars) were quanti- tors also showed enhanced proliferation mediated by GM-CSF
fied using a methylcellulose colony assay. GM: granulocytes/macrophages, and developed CML (Passegue et al., 2001). The purified pro-
E: erythroid, Mix: mixed colonies of GM, E, and megakaryocytic cells. The
genitors in SPA-1/ mice, however, revealed no evidence ofmeans and SE of triplicate cultures are indicated. Similar results were ob-
hypersensitivity to GM-CSF or other hematopoietic factors,tained in three SPA-1/ mice.
B: BMC from the 3- and 8-month-old preleukemic SPA-1/ (closed columns) making significant contribution of Rap1 signaling at the down-
and control (open columns) littermates were analyzed by three-color stain- stream of these hematopoietic factors rather unlikely. In addition
ing using FITC-conjugated mixtures of lineage markers (anti-Thy1, anti-B220, to the hematopoietic factors, it is shown that adhesive interac-anti-Gr-1, anti-Ter-119), PE-conjugated anti-Sca-1, and APC-conjugated
tion of the progenitors with stroma cells mediated by integrinsanti-c-kit. Representative FACS profiles of the lin populations of 8-month-
old preleukemic SPA-1/ and control mice (left two) as well as the mean is essential for the normal hematopoiesis (Arroyo et al., 1999;
proportions of lin Sca-1high c-kit cells (HSC) in the indicated numbers of Miyake et al., 1991), and integrin-mediated adhesion induces
mice (right) are indicated. * p  0.01. ERK activation linking to cell cycle progression (Wary et al.,
C: Sorted c-kit  cells from the BMC of preleukemic 8-months-old SPA-1/
1996). Considering a pivotal role of Rap1 in integrin activation() and control () mice were cultured in the presence of varying concen-
(Bos et al., 2001; Katagiri et al., 2000), it seems possible thattrations of GM-CSF at 200 cells/well. Viable cell numbers were determined
on day 6 using a flowcytometry, the means and SE of three mice being the persistent Rap1 signaling enhances adhesive interaction of
indicated (left). Aliquots of the cells were analyzed for Gr-1 and Mac-1 the progenitors with stroma cells in the hematopoietic microen-
expression (right). vironment. It may be also possible that Rap1 signaling is in-
volved in the proliferation and/or cell survival induced by the
stroma-derived soluble factors or cell bound ligands.
Majority of the leukemic SPA-1/ mice revealed the blastDiscussion
cells of diverse lineages including myeloid, erythroid, and B
lineage, which were mono- or oligoclonal. Also, cell transferSPA-1 gene was isolated originally from a fetal liver-derived
studies into SCID mice indicated the evidence for coexistenceimmature cell line, whose expression was induced in a prolifera-
of cp-CML progenitors and blast cells in a single mouse. Thus,tive state while repressed in a quiescent state (Hattori et al.,
it was suggested strongly that the leukemia represented blast1995), and encodes a specific GAP for Rap1 GTPases (Kurachi
et al., 1997). Present results have indicated that SPA-1 is a crisis of cp-CML. The blast cells continued to exhibit marked
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Figure 5. Accumulation of Rap1GTP in the hema-
topoietic progenitors of preleukemic SPA-1/
mice and role of Rap1 signaling in normal hema-
topoiesis
A: Lin populations of BMC from preleukemic
SPA-1/, and control mice were lysed, and
Rap1GTP/total Rap1, RasGTP/total Ras, and
phosphorylated ERK/total ERK were detected.
B: Sorted lin BMC from normal BALB/c mice pre-
treated with 5-FU (150 mg/kg) were infected with
MIE retrovirus containing RapE63 cDNA, SPA-1
cDNA, or with a vector alone as a control. The
infected cells were cultured on PA6 stroma cells
at 500 cells/well and the numbers of floating
CD45GFP cells (solid columns) and those un-
derneath the stroma cells (shaded columns)
were determined on day 10 (left). The means
and SE of triplicate cultures are indicated. * p 
0.05. They were also transferred into lethally irradi-
ated BALB/c mice (two mice each), and GFP
cell numbers in the recipient BMs were deter-
mined 3 weeks later (right). A solid column repre-
sents each recipient.
C: BM and spleen cells from the recipients of MIE/
RapE63- or empty MIE-retrovirus-infected pro-
genitors were analyzed for Gr-1 and Mac-1 ex-
pression in each of GFP and GFP fractions.
accumulation of Rap1GTP, consisting with the differentiation caused aggressive leukemia with tissue infiltrations similar to
the disease seen in the original SPA-1/ mice. The resultsarrest at earlier stages before significant rapGAP expression. In
contrast to the preleukemic progenitors, the blast cells showed reinforced that the constitutive Ras-ERK activation was neces-
sary but not sufficient for the leukemogenesis in vivo and thatconstitutive Ras activation associated with marked ERK activa-
tion. To investigate the roles of Rap1 signaling in the blast cells, additional Rap1 signaling played a crucial role for it. It is indi-
cated that the blast crisis of cp-CML is associated with addi-we established a cell line (1629B) from a SPA-1/ with CML
in crisis, which showed immortalized growth in vitro only in the tional genetic changes (Kabarowski and Witte, 2000; Wolff,
1997). In mouse models, it was shown that the development ofpresence of stroma cells. 1629B cells exhibited both Rap1GTP
accumulation and constitutive Ras-ERK activation like the blast AML by leukemogenic fusion genes primarily affecting hemato-
poietic progenitors such as PML-RARA, AML1-ETO, and MLL-cells in vivo and caused lethal leukemia and anemia in SCID
mice, indicating that they represented the leukemic blast cells AF9 required the cooperating genetic changes (Brown et al.,
1997; Corral et al., 1996; Higuchi et al., 2002). For instance,in an original SPA-1/ mouse. While restoring SPA-1 gene in
1629B cells completely abrogated Rap1GTP accumulation, as conditional AML1-ETO knockin mice that showed enhanced
self-renewal potential of HSC developed overt AML only afterexpected, it did not affect the constitutive Ras-ERK activation,
indicating that the Ras activation in blast cells was independent the additional introduction of potent mutagenesis in vivo (Hi-
guchi et al., 2002). Because the constitutive Ras activation,of Rap1 signaling. In vitro growth of both 1629B and 1629B/
SPA-1 cells in the presence of stroma cells was inhibited com- which was not observed in the preleukemic progenitors, was
independent of SPA-1 deficiency per se, it was suggested topletely by a MEK-inhibitor. On the other hand, in spite of the
retained Ras-ERK activation after the depletion of stroma cells, reflect the secondary genetic changes. We found no missense
mutation in H-, K-, and N-Ras genes of 1629B cells (M.H. andthey could not survive in the absence of stroma cells (our unpub-
lished observation). Thus, it was suggested strongly that the N.M., unpublished observation), and possible cooperative
genes remain to be identified. Considering the critical role ofimmortalized growth of 1629B cells was dependent on both
constitutive Ras-ERK signaling to promote cell cycle progres- stroma cells for the immortalization of 1629B cells in vitro, we
speculate that Rap1 signaling may be required for the homingsion and cell survival signal(s) provided by the intimate interac-
tion with stroma cells. and invasion of blast cells into the appropriate tissue environ-
ment and/or successful interaction with proper stroma cellsWhen transferred into SCID mice, 1629B/SPA-1 cells failed
to induce leukemia, while control 1629B/GFP cells rapidly there to develop leukemia (Shimonaka et al., 2003; Uemura and
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Figure 6. Accumulation of Rap1GTP in the blast cells in vivo and suppression of the leukemogenicity of a blast cell line by restoring SPA-1 gene
A: Spleen cells from control mouse, SPA-1/ mouse with cp-CML (over 75% granulocytes) and those in blast crisis (the third lane, 20% blast cells,and the
forth lane, 80% blast cells) were lysed and examined for the activation of Rap1, Ras, and ERK.
B: Phase-contrast picture of 1629B cells growing underneath a stroma cell and May-Giemza stained picture (original magnifications, 200 and 1000,
respectively).
C: 1629B (solid columns) and IL-3-dependent FDC-P2 cells (open columns) were cultured in the absence or presence of hematopoiesis-supporting stroma
cells (PA6, Tst-4), other adherent cells (NIH3T3, F2 endothellial line), or various hematopoietic growth factors for 4 and 2 days, respectively, and the % viable
cell numbers of inputs were determined.
D: Parental 1629B cells, 1629B cells infected with empty MIE retrovirus (1629B/GFP), and those infected with MIE/SPA-1 (1629B/SPA-1) were lysed and
immunoblotted with indicated antibodies. A faint signal of SPA-1 in 1629B/GFP cells was due to the minor contaminated PA6 stroma cells. IL-3-starved FDC-
P2 cells served as a negative control for Rap1, Ras, and ERK activation (left). 1629B/GFP (open columns) and 1629B/SPA-1 (solid columns) were plated on
the monolayers of PA6 stroma cells, PD98059 was added at varying concentrations on day 1, and viable cell numbers were determined on day 3. The
mean growth rates (fold increase in the cell numbers) of duplicate cultures as well as the ERK activation are indicated (right). Results of the latter were
identical in the two cell lines, only that of 1629B/SPA-1 being indicated. Note that PD98059 at 100 M induced complete inhibition of cell growth but no
cell death, unlike the depletion of stroma cells that resulted in the entire cell death.
E: Unirradiated SCID mice were injected i.v. with 1629B/GFP, 1629B/SPA-1, or PBS as a control at one million cells/mouse, and the numbers of leukocyte
and RBC in the PB were counted at 8 weeks (left two). Solid circles indicate the recipients that died before 8 weeks. Survival rates of above groups of
mice (, PBS, 9 mice; , 1629B/GFP, 8 mice; , 1629B/SPA-1, 8 mice) were monitored for over 3 months (right).
F: Presence of transfected SPA-1 cDNA was examined by Southern blotting in the enlarged spleens of leukemic mice injected with 1629B/GFP (at 8 weeks)
or 1629B/SPA-1 cells (at 12 weeks), both of which contained over 95% donor-derived (H-2Kb) blast cells. Inoculated 1629B/SPA-1 and 1629B/GFP cells served
as controls. DNAs were digested with BamHI and probed with a SPA-1 cDNA. An open arrowhead indicates a genomic (mutated) SPA-1 gene (4.7 kb)
and a solid arrowhead a transfected SPA-1 cDNA (3.2 kb).
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mixed genetic backgrounds were used in the present study. SCID mice wereGriffin, 1999). It also remains to be seen whether persistent
obtained from CLEA Japan, Inc.Rap1 signaling predisposes the secondary genetic changes per
se in blast crisis.
Cells and cultures
Long latency was a characteristic feature of the leukemia Stroma (PA6, Tst-4) and other adherent cell lines (NIH3T3, F2) as well as
in SPA-1/ mice, even though significant expansion of the myeloid (32D, FDC-P2) cell lines were maintained in RPMI1640 medium
hematopoietic progenitors within BM was evident as early as supplemented with 10% FCS with additional IL-3 for the latter. To induce
32D cell differentiation, the cells were washed and cultured in the presence3 months. Immune functions of the T cells were normal or rather
of 10 ng/ml G-CSF. 1629B cell line was established from the Dexter-typeenhanced in these young SPA-1/ mice. After around half a
culture of BMC from a SPA-1/ mouse with CML in blast crisis. Afteryear, however, SPA-1/ mice were found to develop progres-
8 weeks of the primary culture, cobblestone-like cell clusters that developedsive T cell immunodeficiency preceding the leukemia develop-
underneath the stroma cells were collected and propagated on a monolayer
ment, which was associated with the increasing accumulation of PA6 stroma cells in the modified DMEM with 10% FCS, 10% NCTC109
of Rap1GTP in the memory phenotype T cells (Ishida et al., 2003). medium, 105M 2-mercaptoethanol, 100 U/ml insulin, 1 mM sodium pyr-
Unlike in the hematopoietic progenitors, excess Rap1GTP in the uvate, 1 mM oxalacetic acid, 0.1 mM NEAA, and 10 mM HEPES (Dupuy et
al., 2001). To separate 1629B and stroma cells, the trypsinized cell suspen-antigen-primed T cells interfered with the Ras-mediated ERK
sion was incubated with rat anti-VCMA-1 antibody and then with anti-rat-Ig-activation and proliferation via antigen receptor stimulation lead-
conjugated Dinabeads (Dynal ASA) followed by magnetic beads separation.ing to anergic state, which might be related to rare T cell leuke-
mia in SPA-1/ mice. Opposite functional effects on T and
Flow cytometry
myeloid cells were reported also in the mice expressing AML1- Two- or three-color flowcytometric analysis was performed with various
ETO oncogene (Higuchi et al., 2002). There are indications that combinations of lineage-specific monoclonal antibodies using FACScan
immune system plays a significant role in the control of myelo- (Beckton Dickinson). Antibodies included anti-Thy1, anti-CD3, anti-B220,
anti-Gr-1, anti-Mac-1, anti-CD41, anti-Ter119, anti-Sca-1, and anti-c-kitproliferative diseases in human and mice (Faderl et al., 1999;
(Pharmingen). To separate lin and lin populations of BMC for biochemicalKolb et al., 1995; Pear et al., 1998), and it is tempting to specu-
analysis, the BMC suspensions were incubated with the cocktail of PE-late that the long latency of leukemia might partly reflect the
conjugated antibodies (anti-Thy1, anti-B220, anti-Gr-1, and anti-Ter119) fol-characteristic age-dependent alteration in the T cell functions
lowed by anti-PE antibody-conjugated magnetic beads and separated using
during preleukemic stages. Auto-Max beads columns (Meltenyl Biotech). A lin Sca-1high c-kit cell frac-
A minor group of SPA-1/ mice developed pancytopenia tion was obtained by cell sorting using a FACS Vantage (Beckton Dickinson).
associated with dysplasic leukocytes, reminiscent of human
MDS. MDS is also a hematopoietic stem cell disorder, sharing Immunoblotting, detection of Rap1GTP, and Southern blotting
For immunoblotting, cells were lysed with lysis buffer (0.5% Triton-X100,several features with CML, including the occurrence in elderly
150 mM NaCl, 50 mM Tris-HCl [pH 7.6], protease and phosphatase inhibitors)population and high risk of progression to AML (Kouides and
with additional 0.1% SDS for BMC and blotted with anti-SPA-1 (TsukamotoBennett, 1996; Heaney and Golde, 1999). It remained to be
et al., 1999), anti-rapGAP, anti-ERK-1, 2, anti-phosphorylated ERK, anti-Ras,
examined carefully whether part of blastic leukemia in SPA-1/ or anti-Rap1 (Santa Cruz Biotechnology) followed by peroxidase-labeled
mice was preceded by the MDS-like condition. Although factors second antibodies. To detect Rap1GTP and RasGTP, cell lysate (0.5 to 1 mg
affecting the variable disease types in SPA-1/ mice remained proteins) was precipitated with GST fusion proteins of RalGDS-RBD and
to be determined, possible factors might include the genetic c-Raf-1-RBD coupled with glutathione-Sepharose beads for an hour in ice,
washed, eluted with SDS sample buffer, and immunoblotted with anti-Rap1backgrounds, either 129 or C57Bl/6, and the altered T cell func-
and anti-Ras antibodies, respectively. DNAs of liver and spleens were di-tions that could affect normal hematopoiesis. Development of
gested with EcoRI and BamHI, and Southern blotting was done using ansevere often life-threatening macrocytic anemia was observed
immunoglobulin JH gene cDNA as a probe.in the vast majority of SPA-1/ mice, and our unpublished
results indicated that in vitro erythroid cell differentiation from Histohematologic procedures
SPA-1/ ES cells was impaired at the terminal stages, which Blood sampling was made routinely from the retro-orbital plexus, and the
could be compensated for by erythropoietin (T. Nakano and numbers of leukocytes and RBC as well as the mean corpuscular volume
(MCV) were counted using an automated cell counter (Nihon Kohden, Tokyo).N.M., unpublished observations). Thus, the anemia could be
Cytospin preparations of RBC-lysed blood were stained with May-Grunwalddue in part to the intrinsic effects of SPA-1 deficiency on erythro-
Giemza solution, and organs were fixed in 10% formalin and stained withpoiesis in addition to the ineffective erythropoiesis secondary
hematoxylin-eosin solution. CFU-C assay was performed as described be-
to the myeloid leukemia. Human SPA-1 gene is mapped at fore (Nishi et al., 1990). Briefly, cell suspensions from BM, spleen, and PB
chromosome 11q13 (Wada et al., 1997), one of the cytogeneti- (4  105 or 5  105 cells/35 mm dish) were cultured in the serum-free
cally promiscuous sites in human hematological malignancy methylcellulose medium (-MEM, 0.9% methylcellulose, 1% deionized BSA,
0.05 mM 2-mercaptoethanol) supplemented with SCF (100 ng/ml), IL-6 (100(Wong, 1999), and possible involvement of SPA-1 gene in hu-
ng/ml), IL-3 (20 ng/ml), erythropoietin (2 U/ml), G-CSF (10 ng/ml), and throm-man myeloproliferative disorders needs to be investigated.
bopoietin (10 ng/ml). Numbers of various types of CFU-C were scored at
day 10.Experimental procedures
Retrovirus infectionGeneration of SPA-1-deficient mice
Lin BMC were sorted using a cell sorter from normal BALB/c mice injectedE14 ES cells were transfected with a linearized SPA-1 gene-targeting vector,
with 5-FU (150 mg/kg) 5 days before, cultured in the complete RPMI con-in which a region covering exons 5 to 8 encoding GRD was replaced by a
taining SCF (50 ng/ml), Flk-L (10 ng/ml), IL-6 (10 ng/ml), and IL-11 (10 ng/1.8 kb fragment containing a pgk-neo cassette, by electroporation and se-
ml) for 1 day, infected with recombinant MIE retrovirus (Hawley et al., 1994)lected in the medium containing G418 (125 g/ml) followed by the screening
containing RapE63 or SPA-1 cDNA. Infection efficiency was 20% to 25%.with Southern blot analysis using TP4 and neo probes (Figure 1B). Correctly
1629B cells depleted of stroma cells were infected with recombinant MIE-targeted ES clones were microinjected into C57BL/6 (B6) blastocysts, and
SPA-1 or empty MIE retrovirus as a control for 3 hr, cultured on the PA6the resulting chimaeras were mated with B6 mice. Heterozygous offspring
were intercrossed to produce homozygous mutant mice, and those with stroma cells for a week, and GFP cells were sorted twice using a cell sorter.
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Dupuy, A.J., Morgan, K., von Lintig, F.C., Shen, H., Acar, H., Hasz, D.E.,Transfected SPA-1 cDNA was detected by Southern blotting of the BamHI-
Jenkins, N.A., Copeland, N.G., Boss, G.R., and Largaespada, D.A. (2001).digested DNA.
Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I,
in BXH-2 murine myeloid leukemia. J. Biol. Chem. 276, 11804–11811.Cell transfers
Cells from PB, spleens, and BMs of SPA-1/ mice or control littermates Faderl, S., Talpaz, M., Estrov, Z., O’Brien, S., Kurzrock, R., and Kantarjian,
were washed in PBS and injected intravenously to the 2.75 Gy -ray-irradi- H.M. (1999). The biology of chronic myeloid leukemia. N. Engl. J. Med. 341,
ated SCID mice at 5–10  106 cells/mouse. 1629B cells were transferred 164–172.
intravenously into unirradiated SCID mice at 106 cells/mouse. BM progenitors
Gao, Q., Srinivasan, S., Boyer, S.N., Wazer, D.E., and Band, V. (1999). Theof normal BALB/c mice infected with MIE-retrovirus were transferred intrave-
E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAPnously into 9 Gy -ray-irradiated BALB/c mice at 105 cells/mouse along with
protein, E6TP1, and target it for degradation. Mol. Cell. Biol. 19, 733–744.normal BMC (105 cells/mouse).
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